论文部分内容阅读
[目的]通过对糖尿病临床患者血清C肽浓度的研究,探讨血清C肽浓度对临床用药的指导。[方法]将所研究的90例患者分为两组,观察组根据血清C肽浓度的不同采用不同的治疗方案,对照组按照传统的方法进行治疗,最后对两组的治疗结果进行比较。[结果]对两组患者采用不同的治疗方案后,在观察组的45例患者中有38例用药有效,7例无效,有效率为84.44%;对照组的45例患者,有30例治疗有效,15例无效,有效率为66.67%。[结论]对C肽浓度不同的糖尿病患者采取不同的治疗方案,可以得到较好的治愈效果。
[Objective] To study the serum C-peptide concentration in clinical patients with diabetes to explore the clinical guidance of serum C-peptide concentration. [Methods] The 90 patients were divided into two groups. The observation group received different treatment regimens according to the serum C-peptide concentration. The control group was treated according to the traditional method. Finally, the treatment results of the two groups were compared. [Results] After using different treatment regimens, 38 of the 45 patients in the observation group were effective, 7 were ineffective, and the effective rate was 84.44%. In 45 patients in the control group, 30 were effective , 15 cases were invalid, the effective rate was 66.67%. [Conclusion] Different treatment programs for diabetic patients with different concentrations of C-peptide can achieve better curative effect.